Exo Recruits Former Medtronic CEO to its Board

Exo Imaging has negotiated a strategic collaboration with Samsung Medison to co-develop advanced ultrasound solutions. The partnership includes a strategic equity investment by Samsung, aimed at accelerating the creation of next-generation ultrasound platforms.

“Our collaboration with Exo marks a significant step toward advancing transformation in ultrasound imaging. We are committed to delivering innovation that improves diagnostic capabilities and enhances the clinical experience for patients and practitioners alike,” Samsung Medison CEO Dr. Kyu Tae Yoo said.

Exo also welcomed former Medtronic Chairman/CEO Omar Ishrak to its Board of Directors, appointing him chair of Strategy.

“Exo’s technology has the potential to significantly improve diagnostic precision and accessibility. I look forward to helping guide the clinical strategy and long-term vision behind this important collaboration,” stated Ishrak, chairman of Qubit Health Capital  and GE Healthcare Systems CEO. 

Exo is attempting to pioneer a new era in ultrasound by combining advanced silicon-based architectures with embedded ultrasound technology. The company aims to create imaging systems that are compact and high-performance, with potential applications across various care settings. The Samsung Medison collaboration is expected to lay the foundation for future innovation in real-time imaging.

Exo is redefining medical imaging with its advanced ultrasound platform, combining novel silicon-based hardware, tightly coupled artificial intelligence, and easy-to-use collaboration software. Its handheld and soon-to-be OEM-integrated systems deliver high-performance imaging and real-time clinical intelligence, driving better, more accessible diagnostics and outcomes across diverse care settings.

Founded 40 years ago, Samsung Medison is the largest manufacturer of ultrasound diagnostic systems in Korea and handles domestic sales and service of Samsung Electronics’ digital X-ray systems, and portable CTs. The company has integrated information technology, video signal processing, semiconductor, and communication technologies in various medical fields to develop supplementary diagnostic AI tools for quick and accurate diagnosis. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating IT, image processing, semiconductor, and communication technologies into medical devices.